Mesoblast
(OTC) MEOBF
Mesoblast Financials at a Glance
Market Cap
$2.00B
Revenue (TTM)
$17.20M
Net Income (TTM)
-$102.14M
EPS (TTM)
-$0.07
P/E Ratio
-21.03
Dividend
$0.00
Beta (Volatility)
-0.15 (Low)
Dividend
$0.00
Beta (Volatility)
-0.15 (Low)
Price
$1.55
Volume
135
Open
$1.55
Price
$1.55
Volume
135
Open
$1.55
Previous Close
$1.55
Daily Range
$1.55 - $1.55
52-Week Range
$0.97 - $2.59
Estimated Earnings Date
Sep 2, 2026
Dividend
$0.00
Beta (Volatility)
-0.15 (Low)
Price
$1.55
Volume
135
Open
$1.55
Previous Close
$1.55
Daily Range
$1.55 - $1.55
52-Week Range
$0.97 - $2.59
Estimated Earnings Date
Sep 2, 2026
MEOBF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mesoblast
Industry
Biotechnology
Sector
Health CareEmployees
81
CEO
Silviu Itescu, PhD
Website
www.mesoblast.comHeadquarters
Melbourne, VIC 3000, AU
MEOBF Financials
Key Financial Metrics (TTM)
Gross Margin
-53.34%
Operating Margin
-223.08%
Net Income Margin
-144.33%
Return on Equity
-16.10%
Return on Capital
-8.61%
Return on Assets
-12.06%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.00B
Shares Outstanding
1.29B
Volume
135
Avg. Volume
52.06K
Financials (TTM)
Gross Profit
-$35.86M
Operating Income
-$109.97M
EBITDA
-$58.18M
Operating Cash Flow
-$51.19M
Capital Expenditure
-$1.33M
Free Cash Flow
-$52.52M
Cash & ST Invst.
$129.58M
Total Debt
$135.14M
Mesoblast Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.02M
+458.6%
Gross Profit
-$16.23M
-69.4%
Gross Margin
-2.31%
N/A
Market Cap
$2.00B
N/A
Market Cap/Employee
$27.45M
N/A
Employees
73
N/A
Net Income
-$27.10M
+2.2%
EBITDA
-$19.64M
-28.7%
Quarterly Fundamentals
Total Cash
$129.58M
+240.7%
Total Debt
$135.14M
+7.2%
Accounts Receivable
$43.30M
+2465.2%
Inventory
$21.66M
-10.5%
Long Term Debt
$66.02M
-37.8%
Short Term Debt
$69.12M
+247.6%
Return on Assets
-12.06%
N/A
Return on Invested Capital
-22.29%
N/A
Free Cash Flow
-$4.46M
+65.2%
Operating Cash Flow
-$4.11M
+67.6%